UK yes hybrid embryo R&D
This article was originally published in Clinica
Executive Summary
The UK's Human Fertilisation and Embryology Authority (HFEA) today announced the approval of two licences to conduct research using human-animal cytoplasmic hybrid embryos. Subject to a "series of detailed conditions in each case", Kings College London and Newcastle University will be able to perform the research for a period of one year. The applications were discussed at HFEA licence committee meetings on November 28 2007 and January 9 2008; minutes of the meetings are available from the HFEA (www.hfea.gov.uk).
You may also be interested in...
Mark Cuban ‘Very Involved’, Insists Generics Company CEO
Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.
Bharat Biotech To Make GSK’s Malaria Vaccine For WHO
GSK is transferring technology to make its malaria vaccine antigen to Bharat Biotech and by 2029 will also transfer rights to supply the vaccine to WHO-approved immunization programs. The deal is expected to improve access via lower cost of the vaccine for such programs
Irish Ad Code Covers OTC Devices And Herbals For First Time
Rules covering OTC medical devices, herbals and online activities have been added for the first time to the Irish Pharmaceutical Healthcare Association's Self-Care Advertising Code.
Need a specific report? 1000+ reports available
Buy Reports